Recon: Pfizer, Novo escalate bidding war over Metsera; Merck lands $700M from Blackstone to develop investigational cancer drug
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States